logo

Lyell Immunopharma Inc (LYEL) Stock: A Year of Stock Market Ups and Downs

VIPS stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lyell Immunopharma Inc’s current trading price is -82.12% away from its 52-week high, while its distance from the 52-week low is 14.30%. The stock’s price range over this period has fluctuated between $0.51 and $3.26. The company, operating within the financial sector, had a trading volume of approximately 3.33 million for the day, which was noticeably higher than the average daily share volume of 1.23 million over the last 3 months.

The market performance of Lyell Immunopharma Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $3.26 on 03/04/24, while the lowest value for the same duration was $0.51 on 02/11/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Lyell Immunopharma Inc (LYEL) has experienced a quarterly decline of -51.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 170.04M and boasts a workforce of 224 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9094, with a change in price of -0.9780. Similarly, Lyell Immunopharma Inc recorded 1,321,516 in trading volume during the last 100 days, posting a change of -62.69%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for LYEL stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.

LYEL Stock Stochastic Average

Today, Lyell Immunopharma Inc’s raw stochastic average for the past 50 days stands at 13.72%, indicating a decline from the raw stochastic average of the last 20 days, which was 50.91%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 31.70% and 22.41% respectively.

LYEL Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -9.06%. However, over the past six months, we’ve seen a stronger performance of -57.52%. The price of LYEL fallen by 1.31% over the last 30 days. And in the last five days, it has fallen by -1.52%.

Most Popular